Tag: Acute treatment

While head-to-head trials are limited, indirect evidence suggests older triptans like Imitrex may be more effective for some patients, whereas newer CGRP inhibitors like Ubrelvy offer a crucial alternative for those with cardiovascular risks. Determining which is better, Imitrex or Ubrelvy, depends heavily on individual health factors, tolerability, and cost considerations.

According to the American Migraine Foundation, migraine affects approximately 15% of Americans, causing debilitating head pain and other symptoms. A **migraine tablet**, whether taken acutely or preventively, is designed to interrupt the complex neurological and vascular pathways responsible for these attacks, offering much-needed relief.